CC
SLXP

Clearline Capital’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Clearline Capital’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-185,851
Closed -$32.1M – 89
2015
Q1 		$32.1M Buy
185,851
+23,533
+14% +$3.45M 4.81% 3
2014
Q4 		$18.7M Buy
+162,318
New +$19.7M 2.89% 13

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Clearline Capital's SLXP Position: Q2 2015 in Review

Clearline Capital sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 185,851 shares — an estimated $32.1M sold.

Clearline Capital first reported a position in SLXP in Q4 2014 and held it in 2 quarters. The position peaked at $32.1M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Clearline Capital reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Clearline Capital sold 185,851 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $32.1M.
  • Clearline Capital first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 2 quarters.
  • Clearline Capital's SALIX PHARMACEUTICALS LTD DEL position peaked at $32.1M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Clearline Capital's 13F filing for Q2 2015, filed 14 Aug 2015.